BACITRACIN FOR INJECTION, USP 50000 UNIT
BACITRACIN : 50000 UNIT · DIN 02491109 · AURO PHARMA INC
Health Canada status: APPROVED
What is BACITRACIN FOR INJECTION, USP?
BACITRACIN FOR INJECTION, USP 50000 UNIT contains BACITRACIN : 50000 UNIT. It is listed in the Health Canada Drug Product Database under DIN 02491109, held by AURO PHARMA INC, supplied as POWDER FOR SOLUTION for TOPICAL ; INTRAMUSCULAR administration. Health Canada currently lists it as approved, status dated 29-Jul-2019. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02491109 |
|---|---|
| Brand name | BACITRACIN FOR INJECTION, USP |
| Generic / active ingredient | BACITRACIN : 50000 UNIT |
| Manufacturer | AURO PHARMA INC |
| Strength | 50000 UNIT |
| Dosage form | POWDER FOR SOLUTION |
| Route of administration | TOPICAL ; INTRAMUSCULAR |
| Schedule | Prescription |
| ATC code | J01XX10 BACITRACIN |
| AHFS class | 08:12.28.08 ; 84:04.04 |
| Biosimilar | No |
| Health Canada status | APPROVED |
| Status date | 29-Jul-2019 |
What can be used instead?
Other Canadian products sharing ATC code J01XX10 BACITRACIN. 1 of 5 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| BACIJECT | 50000 UNIT | POWDER FOR SOLUTION | STERIMAX INC | MARKETED | DIN 02245571 |
| BACITRACIN FOR INJECTION | 50000 UNIT | POWDER FOR SOLUTION | FRESENIUS KABI CANADA LTD | CANCELLED PRE MARKET | DIN 02255820 |
| BACITRACIN FOR INJECTION, USP | 50000 UNIT | POWDER FOR SOLUTION | EUGIA PHARMA INC. | APPROVED | DIN 02528665 |
| BACITRACIN USP | 50000 UNIT | POWDER FOR SOLUTION | PFIZER CANADA ULC | CANCELLED POST MARKET | DIN 00030708 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.